Cargando…
Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR
BACKGROUND: The human chromosome 14q32.2 imprinted region harbors the primary MEG3/DLK1:IG-differentially methylated region (DMR) and secondary MEG3:TSS-DMR. The MEG3:TSS-DMR can remain unmethylated only in the presence of unmethylated MEG3/DLK1:IG-DMR in somatic tissues, but not in the placenta, be...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407230/ https://www.ncbi.nlm.nih.gov/pubmed/30846001 http://dx.doi.org/10.1186/s13148-019-0640-2 |
_version_ | 1783401502872698880 |
---|---|
author | Kagami, Masayo Yanagisawa, Atsuhiro Ota, Miyuki Matsuoka, Kentaro Nakamura, Akie Matsubara, Keiko Nakabayashi, Kazuhiko Takada, Shuji Fukami, Maki Ogata, Tsutomu |
author_facet | Kagami, Masayo Yanagisawa, Atsuhiro Ota, Miyuki Matsuoka, Kentaro Nakamura, Akie Matsubara, Keiko Nakabayashi, Kazuhiko Takada, Shuji Fukami, Maki Ogata, Tsutomu |
author_sort | Kagami, Masayo |
collection | PubMed |
description | BACKGROUND: The human chromosome 14q32.2 imprinted region harbors the primary MEG3/DLK1:IG-differentially methylated region (DMR) and secondary MEG3:TSS-DMR. The MEG3:TSS-DMR can remain unmethylated only in the presence of unmethylated MEG3/DLK1:IG-DMR in somatic tissues, but not in the placenta, because of a hierarchical regulation of the methylation pattern between the two DMRs. METHODS: We performed molecular studies in a 4-year-old Japanese girl with Temple syndrome (TS14). RESULTS: Pyrosequencing analysis showed extremely low methylation levels of five CpGs at the MEG3:TSS-DMR and grossly normal methylation levels of four CpGs at the MEG3/DLK1:IG-DMR in leukocytes. HumanMethylation450 BeadChip confirmed marked hypomethylation of the MEG3:TSS-DMR and revealed multilocus imprinting disturbance (MLID) including mild hypomethylation of the H19/IGF2:IG-DMR and mild hypermethylation of the GNAS A/B:TSS-DMR in leukocytes. Bisulfite sequencing showed markedly hypomethylated CpGs at the MEG3:TSS-DMR and irregularly and non-differentially methylated CpGs at the MEG3/DLK1:IG-DMR in leukocytes and apparently normal methylation patterns of the two DMRs in the placenta. Maternal uniparental disomy 14 and a deletion involving this imprinted region were excluded. CONCLUSIONS: Such a methylation pattern of the MEG3/DLK1:IG-DMR has not been reported in patients with TS14. It may be possible that a certain degree of irregular hypomethylation at the MEG3/DLK1:IG-DMR has prevented methylation of the MEG3:TSS-DMR in somatic tissues and that a hypermethylation type MLID has occurred at the MEG3/DLK1:IG-DMR to yield the apparently normal methylation pattern in the placenta. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-019-0640-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6407230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64072302019-03-21 Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR Kagami, Masayo Yanagisawa, Atsuhiro Ota, Miyuki Matsuoka, Kentaro Nakamura, Akie Matsubara, Keiko Nakabayashi, Kazuhiko Takada, Shuji Fukami, Maki Ogata, Tsutomu Clin Epigenetics Short Report BACKGROUND: The human chromosome 14q32.2 imprinted region harbors the primary MEG3/DLK1:IG-differentially methylated region (DMR) and secondary MEG3:TSS-DMR. The MEG3:TSS-DMR can remain unmethylated only in the presence of unmethylated MEG3/DLK1:IG-DMR in somatic tissues, but not in the placenta, because of a hierarchical regulation of the methylation pattern between the two DMRs. METHODS: We performed molecular studies in a 4-year-old Japanese girl with Temple syndrome (TS14). RESULTS: Pyrosequencing analysis showed extremely low methylation levels of five CpGs at the MEG3:TSS-DMR and grossly normal methylation levels of four CpGs at the MEG3/DLK1:IG-DMR in leukocytes. HumanMethylation450 BeadChip confirmed marked hypomethylation of the MEG3:TSS-DMR and revealed multilocus imprinting disturbance (MLID) including mild hypomethylation of the H19/IGF2:IG-DMR and mild hypermethylation of the GNAS A/B:TSS-DMR in leukocytes. Bisulfite sequencing showed markedly hypomethylated CpGs at the MEG3:TSS-DMR and irregularly and non-differentially methylated CpGs at the MEG3/DLK1:IG-DMR in leukocytes and apparently normal methylation patterns of the two DMRs in the placenta. Maternal uniparental disomy 14 and a deletion involving this imprinted region were excluded. CONCLUSIONS: Such a methylation pattern of the MEG3/DLK1:IG-DMR has not been reported in patients with TS14. It may be possible that a certain degree of irregular hypomethylation at the MEG3/DLK1:IG-DMR has prevented methylation of the MEG3:TSS-DMR in somatic tissues and that a hypermethylation type MLID has occurred at the MEG3/DLK1:IG-DMR to yield the apparently normal methylation pattern in the placenta. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-019-0640-2) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-07 /pmc/articles/PMC6407230/ /pubmed/30846001 http://dx.doi.org/10.1186/s13148-019-0640-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Short Report Kagami, Masayo Yanagisawa, Atsuhiro Ota, Miyuki Matsuoka, Kentaro Nakamura, Akie Matsubara, Keiko Nakabayashi, Kazuhiko Takada, Shuji Fukami, Maki Ogata, Tsutomu Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR |
title | Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR |
title_full | Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR |
title_fullStr | Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR |
title_full_unstemmed | Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR |
title_short | Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR |
title_sort | temple syndrome in a patient with variably methylated cpgs at the primary meg3/dlk1:ig-dmr and severely hypomethylated cpgs at the secondary meg3:tss-dmr |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407230/ https://www.ncbi.nlm.nih.gov/pubmed/30846001 http://dx.doi.org/10.1186/s13148-019-0640-2 |
work_keys_str_mv | AT kagamimasayo templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr AT yanagisawaatsuhiro templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr AT otamiyuki templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr AT matsuokakentaro templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr AT nakamuraakie templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr AT matsubarakeiko templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr AT nakabayashikazuhiko templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr AT takadashuji templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr AT fukamimaki templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr AT ogatatsutomu templesyndromeinapatientwithvariablymethylatedcpgsattheprimarymeg3dlk1igdmrandseverelyhypomethylatedcpgsatthesecondarymeg3tssdmr |